Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study
Australasian Journal of Dermatology · 2026
DOI: 10.1111/ajd.70039 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Australasian Journal of Dermatology, 2026. Verfasst von Karen Koch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Waikato Hospital, Hamilton, Waikato, New Zealand. Hauptthemen laut MEDLINE: Vildagliptin, Pemphigoid, Bullous, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Bullous pemphigoid (BP) is a common autoimmune blistering disease associated with medications, particularly dipeptidyl peptidase‐4 inhibitors such as vildagliptin, funded in New Zealand since 2018. We conducted a retrospective single‐centre study of histologically confirmed BP cases between 2018 and 2023. Of 49 patients identified, 15 (30.6%) had vildagliptin‐induced BP. Māori patients were over‐represented in this subgroup. The mean time to BP onset after vildagliptin initiation was 388 days. Non‐vildagliptin BP was more likely to require systemic immunosuppression. Vildagliptin‐induced BP represents a common and under‐recognised clinical entity in New Zealand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Waikato Hospital, Hamilton, Waikato, New Zealand.
- Medical School, University of Auckland, Auckland, Auckland, New Zealand.
ORCID-Profile: Karen Koch
Zitieren
APA
Koch, K., & Lim, B. (2026). Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70039
Vancouver
Koch K, Lim B. Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study. Australasian Journal of Dermatology. 2026. doi:10.1111/ajd.70039
BibTeX
@article{Koch2026,
author = {Koch, Karen and Lim, Breana},
title = {Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study},
journal = {Australasian Journal of Dermatology},
year = {2026},
doi = {10.1111/ajd.70039}
}
EUVIMED